Muscle Relaxants Market Size, Share, Analysis Report

Muscle Relaxants Market Size, By Product (Peripherally Acting Muscle Relaxants [Neuromuscular Blocking Agents, Direct Acting Muscle Relaxants], Facial Aesthetic Relaxants, Centrally Acting Muscle Relaxants), By Formulation (Solid Oral Formulations, Injectable Formulations), By Distribution Channel (Hospital Pharmacy, Online sales, Retail Pharmacy, Drug Stores), By Region Analysis - Global Forecast

The global muscle relaxants market size will show high growth rate during the study period owing to expanding geriatric population and rising incidence of lower back pain. In the U.S., lower back pain is been recognised as one of the top 5 causes for physician consultation. Additionally, changing prescription practices will positively affect the growth rate of the business.

Purchase User License

MARKET SNAPSHOT

Major Players

  • Abbott Laboratories
  • Mallinckrodt plc
  • Vertical Pharmaceuticals LLC
  • Medtronic Inc
  • Johnson & Johnson
  • Study period:

    2023-2028

    Base Year:

    2022

    CAGR:

    7

    Fastest Growing Market:

    APAC

    Largest Market:

    North America

    REPORT DESCRIPTION

    The global muscle relaxants market size will show high growth rate during the study period owing to expanding geriatric population and rising incidence of lower back pain. In the U.S., lower back pain is been recognised as one of the top 5 causes for physician consultation. Additionally, changing prescription practices will positively affect the growth rate of the business.

    In 2007, the American Pain Society and American College of Physicians provided guidelines for lower back pain treatment which includes skeletal muscle relaxants. However, severe side effects associated with the muscle relaxant drugs such as respiratory arrest and habituation may hinder the industry size.

    Global muscle relaxants market is segregated on the basis of product as, Peripherally Acting Muscle Relaxants, Facial Aesthetic Relaxants, and Centrally Acting Muscle Relaxants. Based on formulation, the global muscle relaxants market is segmented as Solid Oral Formulations, and Injectable Formulations. The report also bifurcates global muscle relaxants market based on distribution channel as Hospital Pharmacy, Online sales, Retail Pharmacy, and Drug Stores.

    Global muscle relaxants market report provides geographic analysis covering regions such as North America, Europe, Asia Pacific, and Rest of World. The muscle relaxants market for each region is further segmented for major countries including U.S., Canada, Germany, UK, France, Italy, China, India, Japan, Brazil, South Africa and others.

    Competitive Rivalry

    Abbott Laboratories, Mallinckrodt plc., Vertical Pharmaceuticals LLC, Medtronic Inc., Johnson & Johnson, Endo Pharmaceuticals, Inc., Sanofi, Novartis, Par Sterile Products, LLC., SteriMax Inc. are among the major players in the global muscle relaxants market share. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.

    The Muscle Relaxants Market has been segmented as below:

    Muscle Relaxants Market, By Product

    • Peripherally Acting Muscle Relaxants
      • Neuromuscular Blocking Agents
      • Direct Acting Muscle Relaxants
    • Facial Aesthetic Relaxants
    • Centrally Acting Muscle Relaxants

    Muscle Relaxants Market, By Formulations

    • Solid Oral Formulations
    • Injectable Formulations

    Muscle Relaxants Market, By Distribution Channel

    • Hospital Pharmacy
    • Online sales
    • Retail Pharmacy
    • Drug Stores

    Muscle Relaxants Market, By Region

    • North America
    • Europe
    • Asia Pacific
    • Rest of World

    The report covers:

    • Global muscle relaxants market sizes from 2021 to 2028, along with CAGR for 2023-2028
    • Market size comparison for 2022 vs 2028, with actual data for 2022, estimates for 2023 and forecast from 2024 to 2028
    • Global muscle relaxants market trends, covering comprehensive range of consumer trends & manufacturer trends
    • Value chain analysis covering participants from raw material suppliers to the downstream buyer in the muscle relaxants market
    • Major market opportunities and challenges in forecast timeframe to be focused
    • Competitive landscape with analysis on competition pattern, portfolio comparisons, development trends and strategic management
    • Comprehensive company profiles of the key industry players

    Report scope:

    Global muscle relaxants market report scope includes detailed study covering underlying factors influencing the industry trends.

    The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.

    The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global muscle relaxants market share. Major industry players with significant revenue share include Abbott Laboratories, Mallinckrodt plc., Vertical Pharmaceuticals LLC, Medtronic Inc., Johnson & Johnson, Endo Pharmaceuticals, Inc., Sanofi, Novartis, Par Sterile Products, LLC., SteriMax Inc.

    Reasons to Buy this Report:

    • Gain detailed insights on the muscle relaxants industry trends
    • Find complete analysis on the market status
    • Identify the muscle relaxants market opportunities and growth segments
    • Analyse competitive dynamics by evaluating business segments & product portfolios
    • Facilitate strategy planning and industry dynamics to enhance decision making

    Customization:

    Customized report as per the requirement can be offered with appropriate recommendations

    Below are our New Reports :-

    Animal Gelatin Capsule Market

    Aspergillosis Drugs market

    3D Cell Culture Market

    Tick-borne Encephalitis Vaccine market

    urinary tract infection treatment market

    1.    Introduction
        1.1.    Key Points
        1.2.    Report Description
        1.3.    Markets Covered
        1.4.    Stakeholders

    2.    Research Methodology
        2.1.    Research Scope
        2.2.    Research Methodology
            2.2.1.    Market Research Process
            2.2.2.    Research Methodology
                2.2.2.1.    Secondary Research
                2.2.2.2.    Primary Research
                2.2.2.3.    Models for Estimation
        2.3.    Market Size Estimation
            2.3.1.    Bottom-Up Approach
            2.3.2.    Top-Down Approach

    3.    Executive Summary

    4.    Market Overview
        4.1.    Introduction
        4.2.    Drivers
            4.2.1.    Increasing incidence of lower back pain
            4.2.2.    Expanding geriatric population
        4.3.    Restraints
            4.3.1.    Respiratory arrest
        4.4.    Opportunities
            4.4.1.    Distribution through online channel
        4.5.    Challenges
            4.5.1.    High cost of medication

    5.    Muscle Relaxants Market, By Product
        5.1.    Key Points
        5.2.    Peripherally Acting Muscle Relaxants
            5.2.1.    Neuromuscular Blocking Agents
            5.2.2.    Direct Acting Muscle Relaxants
        5.3.    Facial Aesthetic Relaxants
        5.4.    Centrally Acting Muscle Relaxants

    6.    Muscle Relaxants Market, By Formulation
        6.1.    Key Points
        6.2.    Solid Oral Formulations
        6.3.    Injectable Formulations

    7.    Muscle Relaxants Market, By Distribution Channel
        7.1.    Key Points
        7.2.    Hospital Pharmacy
        7.3.    Online sales
        7.4.    Retail Pharmacy
        7.5.    Drug Stores

    8.    Competitive Landscape
        8.1.    Introduction
        8.2.    Recent Developments
            8.2.1.    Mergers & Acquisitions
            8.2.2.    New Product Developments
            8.2.3.    Portfolio/Production Capacity Expansions
            8.2.4.    Joint Ventures, Collaborations, Partnerships & Agreements
            8.2.5.    Others

    9.    Company Profile
        9.1.    Abbott Laboratories
            9.1.1.    Company Overview
            9.1.2.    Product/Service Landscape
            9.1.3.    Financial Overview
            9.1.4.    Recent Developments
        9.2.    Mallinckrodt plc.
            9.2.1.    Company Overview
            9.2.2.    Product/Service Landscape
            9.2.3.    Financial Overview
            9.2.4.    Recent Developments
        9.3.    Vertical Pharmaceuticals LLC
            9.3.1.    Company Overview
            9.3.2.    Product/Service Landscape
            9.3.3.    Financial Overview
            9.3.4.    Recent Developments
        9.4.    Medtronic Inc.
            9.4.1.    Company Overview
            9.4.2.    Product/Service Landscape
            9.4.3.    Financial Overview
            9.4.4.    Recent Developments
        9.5.    Johnson & Johnson
            9.5.1.    Company Overview
            9.5.2.    Product/Service Landscape
            9.5.3.    Financial Overview
            9.5.4.    Recent Developments
        9.6.    Endo Pharmaceuticals, Inc.
            9.6.1.    Company Overview
            9.6.2.    Product/Service Landscape
            9.6.3.    Financial Overview
            9.6.4.    Recent Developments
        9.7.    Sanofi
            9.7.1.    Company Overview
            9.7.2.    Product/Service Landscape
            9.7.3.    Financial Overview
            9.7.4.    Recent Developments
        9.8.    Novartis
            9.8.1.    Company Overview
            9.8.2.    Product/Service Landscape
            9.8.3.    Financial Overview
            9.8.4.    Recent Developments
        9.9.    Par Sterile Products, LLC.
            9.9.1.    Company Overview
            9.9.2.    Product/Service Landscape
            9.9.3.    Financial Overview
            9.9.4.    Recent Developments
        9.10.    SteriMax Inc.
            9.10.1.    Company Overview
            9.10.2.    Product/Service Landscape
            9.10.3.    Financial Overview
            9.10.4.    Recent Developments

    The Muscle Relaxants Market has been segmented as below:

    Muscle Relaxants Market, By Product

    • Peripherally Acting Muscle Relaxants
      • Neuromuscular Blocking Agents
      • Direct Acting Muscle Relaxants
    • Facial Aesthetic Relaxants
    • Centrally Acting Muscle Relaxants

    Muscle Relaxants Market, By Formulations

    • Solid Oral Formulations
    • Injectable Formulations

    Muscle Relaxants Market, By Distribution Channel

    • Hospital Pharmacy
    • Online sales
    • Retail Pharmacy
    • Drug Stores

    Muscle Relaxants Market, By Region

    • North America
    • Europe
    • Asia Pacific
    • Rest of World

    Got a question? We've got answers. If you have some other questions, see our support center.

    The segment included in Muscle Relaxants Market is Product, Formulations, Distribution Channel and region.
    Some key players operating in the Muscle Relaxants Market include Abbott Laboratories, Mallinckrodt plc., Vertical Pharmaceuticals LLC, Medtronic Inc., Johnson & Johnson, Endo Pharmaceuticals, Inc., Sanofi, Novartis
    We can offer several formats of the market research reports including, • PDF • PPT • Spreadsheet/ Workbook

    Related Reports